MBIO: Mustang Bio Inc Financial Statements
Balance sheet, income statement, and cash flow statements for Mustang Bio Inc (MBIO).
$8.46M Market Cap.
MBIO Market Cap. (MRY)
MBIO Shares Outstanding (MRY)
MBIO Assets (MRY)
Total Assets
$9.31M
Total Liabilities
$13.18M
Total Investments
$0
MBIO Income (MRY)
Revenue
$0
Net Income
-$15.75M
Operating Expense
$16.25M
MBIO Cash Flow (MRY)
CF Operations
-$11.41M
CF Investing
$0
CF Financing
$11.27M
MBIO Balance Sheet (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Total Assets | $9,308,000 (-47.54%) | $17,742,000 (-80.80%) | $92,422,000 (-26.16%) | $125,170,000 (13.89%) |
Assets Current | $8,606,000 (-24.15%) | $11,346,000 (-85.61%) | $78,852,000 (-29.41%) | $111,706,000 (12.23%) |
Assets Non-Current | $702,000 (-89.02%) | $6,396,000 (-52.87%) | $13,570,000 (0.79%) | $13,464,000 (29.89%) |
Goodwill & Intangible Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Shareholders Equity | -$3,873,000 (-3248.78%) | $123,000 (-99.73%) | $46,273,000 (-58.83%) | $112,400,000 (14.19%) |
Property Plant & Equipment Net | $1,617,000 (-66.40%) | $4,813,000 (-60.90%) | $12,309,000 (1.71%) | $12,102,000 (32.76%) |
Cash & Equivalents | $6,839,000 (-2.08%) | $6,984,000 (-90.89%) | $76,656,000 (-30.70%) | $110,618,000 (11.96%) |
Accumulated Other Comprehensive Income | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Deferred Revenue | $150,000 (-44.44%) | $270,000 (0.00%) | $270,000 (0.00%) | $270,000 (0%) |
Total Investments | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Investments Non-Current | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Inventory | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Trade & Non-Trade Receivables | $402,000 (-89.64%) | $3,879,000 (10675.00%) | $36,000 (-28.00%) | $50,000 (233.33%) |
Trade & Non-Trade Payables | $12,153,000 (-18.17%) | $14,851,000 (2.44%) | $14,497,000 (38.50%) | $10,467,000 (13.32%) |
Accumulated Retained Earnings (Deficit) | -$396,723,000 (-4.13%) | -$380,971,000 (-15.67%) | -$329,369,000 (-30.78%) | -$251,844,000 (-35.78%) |
Tax Assets | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Tax Liabilities | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Total Debt | $878,000 (-64.85%) | $2,498,000 (-92.04%) | $31,382,000 (1443.63%) | $2,033,000 (-8.75%) |
Debt Current | $456,000 (-12.31%) | $520,000 (-15.03%) | $612,000 (75.86%) | $348,000 (25.18%) |
Debt Non-Current | $422,000 (-78.67%) | $1,978,000 (-93.57%) | $30,770,000 (1726.11%) | $1,685,000 (-13.59%) |
Total Liabilities | $13,181,000 (-25.19%) | $17,619,000 (-61.82%) | $46,149,000 (261.39%) | $12,770,000 (11.38%) |
Liabilities Current | $12,609,000 (-17.97%) | $15,371,000 (1.73%) | $15,109,000 (39.70%) | $10,815,000 (13.66%) |
Liabilities Non-Current | $572,000 (-74.56%) | $2,248,000 (-92.76%) | $31,040,000 (1487.72%) | $1,955,000 (0.26%) |
MBIO Income Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Revenues | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Cost of Revenue | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Selling General & Administrative Expense | $4,135,000 (-57.31%) | $9,686,000 (-20.67%) | $12,210,000 (10.83%) | $11,017,000 (15.91%) |
Research & Development Expense | $8,418,000 (-79.49%) | $41,040,000 (-35.82%) | $63,949,000 (14.80%) | $55,706,000 (17.77%) |
Operating Expenses | $16,245,000 (-67.02%) | $49,260,000 (-35.32%) | $76,159,000 (14.14%) | $66,723,000 (17.46%) |
Interest Expense | $5,000 (-99.88%) | $4,109,000 (22.33%) | $3,359,000 (22293.33%) | $15,000 (-99.62%) |
Income Tax Expense | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Loss Income from Discontinued Operations | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Consolidated Income | -$15,752,000 (69.47%) | -$51,602,000 (33.44%) | -$77,525,000 (-16.81%) | -$66,370,000 (-10.59%) |
Net Income to Non-Controlling Interests | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income | -$15,752,000 (69.47%) | -$51,602,000 (33.44%) | -$77,525,000 (-16.81%) | -$66,370,000 (-10.59%) |
Preferred Dividends Income Statement Impact | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Income Common Stock | -$15,752,000 (69.47%) | -$51,602,000 (33.44%) | -$77,525,000 (-16.81%) | -$66,370,000 (-10.59%) |
Weighted Average Shares | $609,696 (-92.91%) | $8,604,104 (24.78%) | $6,895,541 (17.69%) | $5,859,045 (67.12%) |
Weighted Average Shares Diluted | $609,696 (-92.91%) | $8,604,104 (24.78%) | $6,895,541 (17.69%) | $5,859,045 (67.12%) |
Earning Before Interest & Taxes (EBIT) | -$15,747,000 (66.84%) | -$47,493,000 (35.96%) | -$74,166,000 (-11.77%) | -$66,355,000 (-18.28%) |
Gross Profit | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Operating Income | -$16,245,000 (67.02%) | -$49,260,000 (35.32%) | -$76,159,000 (-14.14%) | -$66,723,000 (-17.46%) |
MBIO Cash Flow Statement (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Net Cash Flow from Investing | $0 (0%) | $5,886,000 (299.39%) | -$2,952,000 (44.99%) | -$5,366,000 (-21.62%) |
Net Cash Flow from Financing | $11,265,000 (143.19%) | -$26,081,000 (-176.58%) | $34,056,000 (-51.93%) | $70,847,000 (-9.31%) |
Net Cash Flow from Operations | -$11,410,000 (76.94%) | -$49,477,000 (23.96%) | -$65,066,000 (-21.24%) | -$53,667,000 (-43.81%) |
Net Cash Flow / Change in Cash & Cash Equivalents | -$145,000 (99.79%) | -$69,672,000 (-105.15%) | -$33,962,000 (-387.47%) | $11,814,000 (-67.54%) |
Net Cash Flow - Business Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Net Cash Flow - Investment Acquisitions and Disposals | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Capital Expenditure | $0 (0%) | $5,936,000 (329.45%) | -$2,587,000 (35.10%) | -$3,986,000 (-107.06%) |
Issuance (Repayment) of Debt Securities | $0 (0%) | -$30,375,000 (-201.25%) | $30,000,000 (0%) | $0 (0%) |
Issuance (Purchase) of Equity Shares | $11,367,000 (139.86%) | $4,739,000 (-30.60%) | $6,829,000 (-90.55%) | $72,228,000 (-25.83%) |
Payment of Dividends & Other Cash Distributions | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Effect of Exchange Rate Changes on Cash | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Share Based Compensation | -$450,000 (-179.23%) | $568,000 (-75.12%) | $2,283,000 (-30.99%) | $3,308,000 (10.75%) |
Depreciation Amortization & Accretion | $823,000 (-63.01%) | $2,225,000 (-26.59%) | $3,031,000 (31.44%) | $2,306,000 (29.19%) |
MBIO Financial Metrics (MRY)
Metric | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|
Gross Margin | - | - | - | - |
Profit Margin | - | - | - | - |
EBITDA Margin | - | - | - | - |
Return on Average Equity (ROAE) | 244.20% (156.38%) | -433.10% (-304.77%) | -107.00% (-102.65%) | -52.80% (35.84%) |
Return on Average Assets (ROAA) | -159.10% (-8.67%) | -146.40% (-117.21%) | -67.40% (-38.40%) | -48.70% (26.66%) |
Return on Sales (ROS) | - | - | - | - |
Return on Invested Capital (ROIC) | 190.00% (132.86%) | -578.20% (-152.82%) | -228.70% (78.16%) | -1047.30% (-77.99%) |
Dividend Yield | 0% (0%) | 0% (0%) | 0% (0%) | 0% (0%) |
Price to Earnings Ratio (P/E) | -0.23 (-1.78%) | -0.23 (57.31%) | -0.53 (75.87%) | -2.18 (34.22%) |
Price to Sales Ratio (P/S) | - | - | - | - |
Price to Book Ratio (P/B) | -2.18 (-102.16%) | 101.16 (10944.10%) | 0.92 (-33.62%) | 1.38 (-45.00%) |
Debt to Equity Ratio (D/E) | -3.4 (-102.38%) | 143.24 (14267.50%) | 1 (774.56%) | 0.11 (-1.72%) |
Earnings Per Share (EPS) | -38.57 (-542.83%) | -6 (46.67%) | -11.25 (1.32%) | -11.4 (33.33%) |
Sales Per Share (SPS) | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Free Cash Flow Per Share (FCFPS) | -18.71 (-269.84%) | -5.06 (48.43%) | -9.81 (0.29%) | -9.84 (12.10%) |
Book Value Per Share (BVPS) | -6.35 (-45471.43%) | 0.01 (-99.79%) | 6.71 (-65.02%) | 19.18 (-31.67%) |
Tangible Assets Book Value Per Share (TABVPS) | 15.27 (640.40%) | 2.06 (-84.62%) | 13.4 (-37.26%) | 21.36 (-31.85%) |
Enterprise Value Over EBIT (EV/EBIT) | 0 (0%) | 0 (0%) | 0 (0%) | -1 (66.67%) |
Enterprise Value Over EBITDA (EV/EBITDA) | -0.37 (-256.73%) | -0.1 (-139.54%) | 0.26 (147.73%) | -0.55 (82.70%) |
Asset Turnover | 0 (0%) | 0 (0%) | 0 (0%) | 0 (0%) |
Current Ratio | 0.68 (-7.45%) | 0.74 (-85.86%) | 5.22 (-49.47%) | 10.33 (-1.26%) |
Dividends | $0 (0%) | $0 (0%) | $0 (0%) | $0 (0%) |
Free Cash Flow (FCF) | -$11,410,000 (73.79%) | -$43,541,000 (35.64%) | -$67,653,000 (-17.35%) | -$57,653,000 (-46.91%) |
Enterprise Value (EV) | $5,540,104 (17.72%) | $4,706,206 (125.15%) | -$18,710,569 (-153.00%) | $35,303,170 (-79.59%) |
Earnings Before Tax (EBT) | -$15,752,000 (69.47%) | -$51,602,000 (33.44%) | -$77,525,000 (-16.81%) | -$66,370,000 (-10.59%) |
Earnings Before Interest Taxes & Depreciation Amortization (EBITDA) | -$14,924,000 (67.03%) | -$45,268,000 (36.36%) | -$71,135,000 (-11.06%) | -$64,049,000 (-17.93%) |
Invested Capital | -$9,262,000 (-337.92%) | -$2,115,000 (-106.60%) | $32,039,000 (455.27%) | $5,770,000 (51.48%) |
Working Capital | -$4,003,000 (0.55%) | -$4,025,000 (-106.31%) | $63,743,000 (-36.82%) | $100,891,000 (12.08%) |
Tangible Asset Value | $9,308,000 (-47.54%) | $17,742,000 (-80.80%) | $92,422,000 (-26.16%) | $125,170,000 (13.89%) |
Market Capitalization | $8,457,104 (-32.03%) | $12,443,206 (-70.64%) | $42,374,431 (-72.68%) | $155,090,170 (-37.19%) |
Average Equity | -$6,450,500 (-154.14%) | $11,915,000 (-83.56%) | $72,484,250 (-42.36%) | $125,750,000 (72.45%) |
Average Assets | $9,903,000 (-71.91%) | $35,250,500 (-69.36%) | $115,031,000 (-15.56%) | $136,226,250 (50.79%) |
Invested Capital Average | -$8,286,750 (-200.88%) | $8,214,500 (-74.67%) | $32,424,250 (411.75%) | $6,336,000 (-33.54%) |
Shares | 955,605 (-89.63%) | 9,217,190 (28.85%) | 7,153,650 (14.85%) | 6,228,552 (43.21%) |
